Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings (Q39386394)

11 September 2017

title

Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings (English)

1 reference

11 September 2017

1 reference

Donald L Patrick

1

1 reference

11 September 2017

Mona L Martin

series ordinal

2

1 reference

11 September 2017

Donald M Bushnell

series ordinal

3

1 reference

11 September 2017

Jacqueline Pesa

series ordinal

4

1 reference

11 September 2017

publication date

1 November 2003

1 reference

11 September 2017

published in

Clinical Therapeutics

1 reference

11 September 2017

volume

25

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

2920-2935

1 reference

A causal model of health status and satisfaction with medical care.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Social psychological determinants of patient satisfaction: a test of five hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

A new treatment satisfaction measure for asthmatics: a validation study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Evaluation of migraineurs' preferences for naratriptan over conventional first-line agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Validation of the Patient Perception of Migraine Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Efficacy, tolerability, and patient satisfaction with 50- and 100-mg sumatriptan tablets in those initially dissatisfied with the efficacy of 50-mg sumatriptan tablets

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

A multinational investigation of the impact of subcutaneous sumatriptan. IV: Patient satisfaction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Migraine therapy: development and testing of a patient preference questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

The characteristics of patient satisfaction measures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Validation of a New Quality of Life Questionnaire for Acute Migraine Headache

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Development of a Brief 24‐Hour Migraine‐Specific Quality of Life Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

Measuring the functional status and well-being of patients with migraine headache.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980345-4

7 January 2021

10.1016/S0149-2918(03)80345-4

Identifiers

DOI

1 reference

11 September 2017

1 reference